Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
breaks-ground-on-new-global-iomedical-esearch-center-in-an-iego-to-accelerate-drug-discovery'>Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery is drawing significant interest across the industry.
New facility will enable end?to?end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel, SwitzerlandApproximately 466,000-square-foot site withAI-enabled discovery capabilities, expected to house about 1,000 employees Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patientsBasel, February 6, 2026 - Novartis today broke ground on a new, state-of-the-art global Biomedical Research center in San Diego, California, designed to provide world-class scientific infrastructure and drug-discovery capabilities to advance the company’s pipeline for patients.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- US stocks today: Wall Street rebounds as tech equities recover, bitcoin steadies
- Centre seeks inputs on proposed income
- Delivering Consistent Infrastructure for Evolving Business Models
- Gujarat records first Gyr calf born through IVF in Amreli
Source: Original →